<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03326778</url>
  </required_header>
  <id_info>
    <org_study_id>INCA</org_study_id>
    <nct_id>NCT03326778</nct_id>
  </id_info>
  <brief_title>Registry to Gather Long-time Results After Surgical Aortic Valve Replacement With a &quot;Rapid Deployment Aortic Valve Prothesis (Edwards Intuity) Combined With Bypss Surgery (CABG)</brief_title>
  <acronym>INCA</acronym>
  <official_title>Register Zur Erhebung Von Langzeitergebnissen Nach Chirurgischem Aortenklappen Ersatz Mit Einer &quot;Rapid Deployment&quot; Aortenklappenprothese (Edwards Intuity) in Kombination Mit Einer Bypassoperation (CABG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Campus Bad Neustadt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Software for Trials Europe GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut für Pharmakologie und Präventive Medizin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Campus Bad Neustadt</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospctive, unrandomized multicentric registry which will enrol patients with an
      indication for aortc valve replacement combined with myocardial reperfusion (CABG). The
      registry will collect patient specific baseline data and established risk scores (Logistic
      Euroscore I &amp; II, STS-Score, KBA Score) to enable us to make an estimate about the
      perioperative risks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aortic replacement combined with coronary bypass surgery has an impact on the risk profile
      for the direct postoperative course and also on the long-time survival perspective.

      The advantage of rapid deployment aortic valve prostheses, like the Edward Intuity Elite
      Valve that is used in this registry, is the greater ease of implantation, because only a few
      sutures are necessary to secure the device compared to a conventional prosthesis, where more
      then ten sutures are needed. In procedures where the aortic valve replacement (AVR) is
      combined with a coronary artery bypass graft (CABG), the use of a rapid deployment valve can
      shorten the duration of cardiac ischemia and the overall intervention duration, which
      possibly has an influence on clinical results.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 26, 2017</start_date>
  <completion_date type="Anticipated">July 2024</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>all-cause mortality</measure>
    <time_frame>30 Days</time_frame>
    <description>death from any reason</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>AVR + CABG</arm_group_label>
    <description>Patient receiving AVR combined with CABG</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AVR and CABG</intervention_name>
    <description>Combined AVR with CABG</description>
    <arm_group_label>AVR + CABG</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with an indication for AVR combined with CABG who will receive an Edwards Intuity
        Elite rapid deployment aortic valve prosthesis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inclusion Criteria:

          -  patients with aortic valve stenosis and coronary heart disease with indication for AVR
             and CABG

          -  patients in who the Edwards Intuity Elite valve is to be implanted

          -  patients who are planned to receive at least one coronary bypass

          -  patients who have signed an informed consent form

        Exclusion Criteria:

          -  Exclusion Criteria:

          -  emergency surgery

          -  re-operation (i.e. any previous opening of pericardium)

          -  additional heart diseases requiring heart surgery (e. g. subvalvular myectomy and
             ablation, but not atrial auricle closure or resection)

          -  legal incapacity or other circumstances that impair the patient's ability to
             understand the nature, meaning or extent of the trial

          -  patients wanting a mechanical prosthesis

          -  patients with contraindications for the Edwards Intuity Elite Valve

          -  acute endocarditis or other systemic infections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anno Diegeler, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Campus Bad Neustadt</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anno Diegeler, Prof.</last_name>
    <phone>+49-(0)9771</phone>
    <phone_ext>662416</phone_ext>
    <email>cachir@herzchirurgie.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Monika Back</last_name>
    <phone>+49-(0)9771</phone>
    <phone_ext>662613</phone_ext>
    <email>monika.back@herzchirurgie.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Campus Bad Neustadt</name>
      <address>
        <city>Bad Neustadt An Der Saale</city>
        <state>Bavaria</state>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anno Diegeler, Prof</last_name>
      <phone>09771-66-2416</phone>
    </contact>
    <contact_backup>
      <last_name>Monika Back</last_name>
      <phone>09771-66-2613</phone>
      <email>monika.back@herzchirurgie.de</email>
    </contact_backup>
    <investigator>
      <last_name>Aris Lenos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2017</study_first_submitted>
  <study_first_submitted_qc>October 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2017</study_first_posted>
  <last_update_submitted>December 4, 2017</last_update_submitted>
  <last_update_submitted_qc>December 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aortic Valve Stenosis</keyword>
  <keyword>Rapid deployment Valve</keyword>
  <keyword>CABG</keyword>
  <keyword>Edwards Intuity Elite</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

